Key Record Dates Identifier: NCT00101348
Brief Title: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

First Submitted : January 7, 2005
First Submitted that Met QC Criteria : January 7, 2005
First Posted : January 10, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : June 10, 2014
Last Update Posted : June 11, 2014 (Estimate)